Thomas McGauley insider trades: Tenax Therapeutics (TENX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Thomas reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | TENX | ↑ Buy | 5,000 | $7.23 | $36K | By Spouse | Nov 19, 2025 (2d) |
| Nov 17, 2025 | TENX | ↑ Buy | 2,000 | $7.34 | $15K | Direct | Nov 19, 2025 (2d) |
| Nov 17, 2025 | TENX | ↑ Buy | 1,000 | $7.35 | $7K | By Child | Nov 19, 2025 (2d) |
| May 24, 2012 | GALT | ↑ Buy | 10,000 | $2.35 | $24K | Direct | May 25, 2012 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TENX insiders
Open-market trades in the last 12 months
About Thomas McGauley's insider trades
Thomas McGauley is Interim CFO at Tenax Therapeutics (TENX). Since May 24, 2012, Thomas has reported 4 open-market purchases worth $82K and no sales on SEC Form 4. In the last 12 months: 3 buys ($58K).
Their filings also include grants and awards (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TENX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.